DNA helicases involved in DNA repair and their roles in cancer

Nature Reviews Cancer

Volumn 13, Issue 8, 2013, Pages 542-558

  Brosh, Robert M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; HELICASE; IRON SULFUR PROTEIN; NUCLEIC ACID; RECQ HELICASE; TUMOR MARKER;

BLOOM SYNDROME; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CELL CYCLE CHECKPOINT; COCKAYNE SYNDROME; DNA DAMAGE; DNA REPAIR; GENETIC DISORDER; GENOME; GENOMIC INSTABILITY; HEMATOLOGIC MALIGNANCY; HOMEOSTASIS; HUMAN; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MENINGIOMA; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NONHUMAN; NUCLEIC ACID STRUCTURE; OSTEOSARCOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SARCOMA; SKIN CANCER; TELOMERE; TELOMERE HOMEOSTASIS; THYROID TUMOR; WERNER SYNDROME; XERODERMA PIGMENTOSUM;

EID: 84881145018     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3560     Document Type: Review

References (229)

1. Singleton, M. R., Dillingham, M. S. & Wigley, D. B. Structure and mechanism of helicases and nucleic acid translocases. Annu. Rev. Biochem. 76, 23-50 (2007).
2. Umate, P., Tuteja, N. & Tuteja, R. Genome-wide comprehensive analysis of human helicases. Commun. Integr. Biol. 4, 118-137 (2011).
3. Abdel-Monem, M. & Hoffmann-Berling, H. Enzymic unwinding of DNA. 1. Purification and characterization of a DNA-dependent ATPase from Escherichia coli. Eur. J. Biochem. 65, 431-440 (1976).
4. Suhasini, A. N. & Brosh, R. M. Jr. Disease-causing missense mutations in human DNA helicase disorders. Mutat. Res. 752, 138-152 (2013).
5. Futami, K., Ogasawara, S., Goto, H., Yano, H. & Furuichi, Y. RecQL1 DNA repair helicase: a potential tumor marker and therapeutic target against hepatocellular carcinoma. Int. J. Mol. Med. 25, 537-545 (2010).
6. Kawabe, T. et al. Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene 19, 4764-4772 (2000).
7. Su, Y. et al. Human RecQL4 helicase plays critical roles in prostate carcinogenesis. Cancer Res. 70, 9207-9217 (2010).
8. Turley, H., Wu, L., Canamero, M., Gatter, K. C. & Hickson, I. D. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells. Br. J. Cancer 85, 261-265 (2001).
9. Chu, W. K. & Hickson, I. D. RecQ helicases: multifunctional genome caretakers. Nature Rev. Cancer 9, 644-654 (2009).
10. Monnat, R. J. Jr. Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin. Cancer Biol. 20, 329-339 (2010).
11. Ellis, N. A. et al. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83, 655-666 (1995).
12. Yu, C. E. et al. Positional cloning of the Werner's syndrome gene. Science 272, 258-262 (1996).
13. Kitao, S. et al. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nature Genet. 22, 82-84 (1999).
14. Siitonen, H. A. et al. Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. Hum. Mol. Genet. 12, 2837-2844 (2003).
15. Van Maldergem, L. et al. Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J. Med. Genet. 43, 148-152 (2006).
16. Lauper, J. M., Krause, A., Vaughan, T. L. & Monnat, R. J. Jr. Spectrum and risk of neoplasia in Werner syndrome: a systematic review. PLoS ONE 8, e59709 (2013).
17. Siitonen, H. A. et al. The mutation spectrum in RECQL4 diseases. Eur. J. Hum. Genet. 17, 151-158 (2009).
18. Li, D. et al. Single nucleotide polymorphisms of RecQ1, RAD54L and ATM genes are associated with reduced survival of pancreatic cancer. J. Clin. Oncol. 24, 1720-1728 (2006).
19. Li, D. et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res. 66, 3323-3330 (2006).
20. Sharma, S. et al. RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol. Cell. Biol. 27, 1784-1794 (2007).
21. Sharma, S. & Brosh, R. M. Jr. Human RECQ1 Is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS ONE 2, e1297 (2007).
22. Parvathaneni, S. et al. Human RECQ1 interacts with Ku70/80 and modulates end-joining of double-strand breaks. PLoS ONE 8, e62481 (2013).
23. Sharma, S., Phatak, P., Stortchevoi, A., Jasin, M. & Larocque, J. R. RECQ1 plays a distinct role in cellular response to oxidative DNA damage. DNA Repair 11, 537-549 (2012).
24. Popuri, V., Croteau, D. L., Brosh, R. M. Jr. & Bohr, V. A. RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures. Cell Cycle 11, 4252-4265 (2012).
25. Arai, A. et al. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma. Cancer Res. 71, 4598-4607 (2011).
26. Futami, K. et al. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Cancer Sci. 99, 71-80 (2008).
27. Futami, K. et al. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci. 99, 1227-1236 (2008).
28. Mendoza-Maldonado, R. et al. The human RECQ1 helicase is highly expressed in glioblastoma and plays an important role in tumor cell proliferation. Mol. Cancer 10, 83 (2011).
29. Ramamoorthy, M. et al. RECQL5 cooperates with topoisomerase IIα in DNA decatenation and cell cycle progression. Nucleic Acids Res. 40, 1621-1635 (2012).
30. Hu, Y. et al. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev. 21, 3073-3084 (2007).
31. Islam, M. N. et al. RecQL5 promotes genome stabilization through two parallel mechanisms-interacting with RNA polymerase II and acting as a helicase. Mol. Cell. Biol. 30, 2460-2472 (2010).
32. Tadokoro, T. et al. Human RECQL5 participates in the removal of endogenous DNA damage. Mol. Biol. Cell 23, 4273-4285 (2012).
33. Wu, Y. & Brosh, R. M. Jr. DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster. Nucleic Acids Res. 40, 4247-4260 (2012).
34. Digiovanna, J. J. & Kraemer, K. H. Shining a light on xeroderma pigmentosum. J. Invest. Dermatol. 132, 785-796 (2012).
35. Levitus, M. et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nature Genet. 37, 934-935 (2005).
36. Levran, O. et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nature Genet. 37, 931-933 (2005).
37. Litman, R. et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8, 255-265 (2005).
38. Capo-chichi, J. M. et al. Identification and biochemical characterization of a novel mutation in DDX11 causing Warsaw breakage syndrome. Hum. Mut. 34, 103-107 (2013).
39. van der, L. P. et al. Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChlR1. Am. J. Hum. Genet. 86, 262-266 (2010).
40. Ballew, B. J. et al. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in dyskeratosis congenita. Hum. Genet. 132, 473-480 (2013).
41. Le Guen, T. et al. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. Hum. Mol. Genet. 15 Apr 2013 (doi:10.1093/hmg/ddt178).
42. Walne, A. J., Vulliamy, T., Kirwan, M., Plagnol, V. & Dokal, I. Constitutional mutations in RTEL1 cause severe dyskeratosis congenita. Am. J. Hum. Genet. 92, 448-453 (2013).
43. Flejter, W. L., McDaniel, L. D., Askari, M., Friedberg, E. C. & Schultz, R. A. Characterization of a complex chromosomal rearrangement maps the locus for in vitro complementation of xeroderma pigmentosum group D to human chromosome band 19q13. Genes Chromosomes Cancer 5, 335-342 (1992).
44. Flejter, W. L., McDaniel, L. D., Johns, D., Friedberg, E. C. & Schultz, R. A. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc. Natl Acad. Sci. USA 89, 261-265 (1992).
45. Kee, Y. & D'Andrea, A. D. Molecular pathogenesis and clinical management of Fanconi anemia. J. Clin. Invest. 122, 3799-3806 (2012).
46. Cantor, S. B. & Guillemette, S. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol. 7, 253-261 (2011).
47. Uringa, E. J. et al. RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol. Biol. Cell 23, 2782-2792 (2012).
48. Vannier, J. B., Pavicic-Kaltenbrunner, V., Petalcorin, M. I., Ding, H. & Boulton, S. J. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149, 795-806 (2012).
49. Barber, L. J. et al. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135, 261-271 (2008).
50. Egan, K. M. et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J. Neurooncol. 104, 535-542 (2011).
51. Shete, S. et al. Genome-wide association study identifies five susceptibility loci for glioma. Nature Genet. 41, 899-904 (2009).
52. Wrensch, M. et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nature Genet. 41, 905-908 (2009).
53. Weeda, G. et al. Molecular cloning and biological characterization of the human excision repair gene ERCC 3. Mol. Cell. Biol. 10, 2570-2581 (1990).
54. Weeda, G. et al. A presumed DNA helicase encoded by ERCC 3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell 62, 777-791 (1990).
55. Gagou, M. E. et al. Suppression of apoptosis by PIF1 helicase in human tumor cells. Cancer Res. 71, 4998-5008 (2011).
56. Chisholm, K. M. et al. A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1. PLoS ONE 7, e30748 (2012).
57. Alzu, A. et al. Senataxin associates with replication forks to protect fork integrity across RNA-Polymerase-II transcribed genes. Cell 151, 835-846 (2012).
58. Yuce-Petronczki, O. & West, S. C. Senataxin, defective in the neurogenerative disorder AOA-2, lies at the interface of transcription and the DNA damage response. Mol. Cell Biol. 33, 406-417 (2012).
59. Kang, Y. H., Lee, C. H. & Seo, Y. S. Dna2 on the road to Okazaki fragment processing and genome stability in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 45, 71-96 (2010).
60. Duxin, J. P. et al. Human Dna2 is a nuclear and mitochondrial DNA maintenance protein. Mol. Cell. Biol. 29, 4274-4282 (2009).
61. Nimonkar, A. V. et al. BLM DNA2 RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev. 25, 350-362 (2011).
62. Zheng, L. et al. Human DNA2 is a mitochondrial nuclease/helicase for efficient processing of DNA replication and repair intermediates. Mol. Cell 32, 325-336 (2008).
63. Copeland, W. C. Defects in mitochondrial DNA replication and human disease. Crit. Rev. Biochem. Mol. Biol. 47, 64-74 (2012).
64. Brosh, R. M. Jr., Waheed, J. & Sommers, J. A. Biochemical characterization of the DNA substrate specificity of Werner syndrome helicase. J. Biol. Chem. 277, 23236-23245 (2002).
65. Suhasini, A. N. & Brosh, R. M. Jr. Mechanistic and biological aspects of helicase action on damaged DNA. Cell Cycle 9, 2317-2329 (2010).
66. Sontz, P. A., Mui, T. P., Fuss, J. O., Tainer, J. A. & Barton, J. K. DNA charge transport as a first step in coordinating the detection of lesions by repair proteins. Proc. Natl Acad. Sci. USA 109, 1856-1861 (2012).
67. Suhasini, A. N. et al. FANCJ helicase uniquely senses oxidative base damage in either strand of duplex DNA and is stimulated by replication protein A to unwind the damaged DNA substrate in a strand-specific manner. J. Biol. Chem. 284, 18458-18470 (2009).
68. Ghosh, A., Rossi, M. L., Aulds, J., Croteau, D. & Bohr, V. A. Telomeric D-loops containing 8 oxo 2′ deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1. J. Biol. Chem. 284, 31074-31084 (2009).
69. Indiani, C. & O'Donnell, M. A. Proposal: source of single strand DNA that elicits the SOS response. Front. Biosci. 18, 312-323 (2013).
70. Honda, M., Park, J., Pugh, R. A., Ha, T. & Spies, M. Single-molecule analysis reveals differential effect of ssDNA-binding proteins on DNA translocation by XPD helicase. Mol. Cell 35, 694-703 (2009).
71. Reardon, J. T. & Sancar, A. Nucleotide excision repair. Prog. Nucleic Acid Res. Mol. Biol. 79, 183-235 (2005).
72. Egly, J. M. & Coin, F. A history of TFIIH: Two decades of molecular biology on a pivotal transcription/repair factor. DNA Repair 10, 714-721 (2011).
73. Sugasawa, K., Akagi, J., Nishi, R., Iwai, S. & Hanaoka, F. Two-step recognition of DNA damage for mammalian nucleotide excision repair: directional binding of the XPC complex and DNA strand scanning. Mol. Cell 36, 642-653 (2009).
74. Mathieu, N., Kaczmarek, N., Ruthemann, P., Luch, A., & Naegeli, H. DNA quality control by a lesion sensor pocket of the xeroderma pigmentosum group D helicase subunit of TFIIH. Curr. Biol. 23, 204-212 (2013).
75. Fuss, J. O. & Tainer, J. A. XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase. DNA Repair 10, 697-713 (2011).
76. Clarkson, S. G. & Wood, R. D. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair 4, 1068-1074 (2005).
77. Deans, A. J. & West, S. C. DNA interstrand crosslink repair and cancer. Nature Rev. Cancer 11, 467-480 (2011).
78. Garaycoechea, J. I. et al. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489, 571-575 (2012).
79. Rosado, I. V., Langevin, F., Crossan, G. P., Takata, M. & Patel, K. J. Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nature Struct. Mol. Biol. 18, 1432-1434 (2011).
80. Adamo, A. et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell 39, 25-35 (2010).
81. Pace, P. et al. Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science 329, 219-223 (2010).
82. Meetei, A. R. et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nature Genet. 37, 958-963 (2005).
83. Singh, T. R. et al. MHF1 MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol. Cell 37, 879-886 (2010).
84. Peng, M. et al. The FANCJ/MutLα interaction is required for correction of the cross-link response in FA-J cells. EMBO J. 26, 3238-3249 (2007).
85. Meetei, A. R. et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23, 3417-3426 (2003).
86. Deans, A. J. & West, S. C. FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia. Mol. Cell 36, 943-953 (2009).
87. Larocque, J. R. et al. Interhomolog recombination and loss of heterozygosity in wild-type and Bloom syndrome helicase (BLM)-deficient mammalian cells. Proc. Natl Acad. Sci. USA 108, 11971-11976 (2011).
88. Luo, G. et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nature Genet. 26, 424-429 (2000).
89. Suhasini, A. N. et al. Interaction between the helicases genetically linked to Fanconi anemia Group J and Bloom's syndrome. EMBO J. 30, 692-705 (2011).
90. Suhasini, A. N. et al. Fanconi anemia Group J helicase and MRE11 nuclease interact to facilitate the DNA damage response. Mol. Cell. Biol. 33, 2212-2227 (2013).
91. Cheng, W. H. et al. Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res. 34, 2751-2760 (2006).
92. Cheng, W. H. et al. WRN Is required for ATM activation and the S-phase checkpoint in response to interstrand crosslink-induced DNA double strand breaks. Mol. Biol. Cell 19, 3923-3933 (2008).
93. Pichierri, P., Ammazzalorso, F., Bignami, M. & Franchitto, A. The Werner syndrome protein: linking the replication checkpoint response to genome stability. Aging 3, 311-318 (2011).
94. Moldovan, G. L. et al. DNA polymerase POLN participates in cross-link repair and homologous recombination. Mol. Cell. Biol. 30, 1088-1096 (2010).
95. Ward, J. D. et al. Overlapping mechanisms promote postsynaptic RAD-51 filament disassembly during meiotic double-strand break repair. Mol. Cell 37, 259-272 (2010).
96. Tafel, A. A., Wu, L. & McHugh, P. J. Human HEL308 localizes to damaged replication forks and unwinds lagging strand structures. J. Biol. Chem. 286, 15832-15840 (2011).
97. Chan, K. L., Palmai-Pallag, T., Ying, S. & Hickson, I. D. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nature Cell Biol. 11, 753-760 (2009).
98. Naim, V. & Rosselli, F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nature Cell Biol. 11, 761-768 (2009).
99. Bernstein, K. A., Gangloff, S. & Rothstein, R. The RecQ DNA helicases in DNA repair. Annu. Rev. Genet. 44, 393-417 (2010).
100. Schwendener, S. et al. Physical interaction of RECQ5 helicase with RAD51 facilitates its anti-recombinase activity. J. Biol. Chem. 285, 15739-15745 (2010).
101. Nimonkar, A. V., Ozsoy, A. Z., Genschel, J., Modrich, P. & Kowalczykowski, S. C. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc. Natl Acad. Sci. USA 105, 16906-16911 (2008).
102. Bugreev, D. V., Yu, X., Egelman, E. H. & Mazin, A. V. Novel pro- and anti-recombination activities of the Bloom's syndrome helicase. Genes Dev. 21, 3085-3094 (2007).
103. Chapman, J. R., Taylor, M. R. & Boulton, S. J. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 47, 497-510 (2012).
104. Cooper, M. P. et al. Ku complex interacts with and stimulates the Werner protein. Genes Dev. 14, 907-912 (2000).
105. Kusumoto, R. et al. Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing. Biochemistry 47, 7548-7556 (2008).
106. Sallmyr, A., Tomkinson, A. E. & Rassool, F. V. Up regulation of WRN and DNA ligase IIIα in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 112, 1413-1423 (2008).
107. Chen, L. et al. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell 2, 191-199 (2003).
108. Perry, J. J. et al. WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing. Nature Struct. Mol. Biol. 13, 414-422 (2006).
109. Swanson, C., Saintigny, Y., Emond, M. J. & Monnat, R. J. Jr. The Werner syndrome protein has separable recombination and survival functions. DNA Repair 3, 475-482 (2004).
110. Kennedy, R. D. et al. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J. Clin. Invest. 117, 1440-1449 (2007).
111. von Kobbe, C. et al. Central role for the Werner syndrome protein/poly(ADP-ribose) polymerase 1 complex in the poly(ADP-ribosyl)ation pathway after DNA damage. Mol. Cell. Biol. 23, 8601-8613 (2003).
112. Woo, L. L., Futami, K., Shimamoto, A., Furuichi, Y. & Frank, K. M. The Rothmund-Thomson gene product RECQL4 localizes to the nucleolus in response to oxidative stress. Exp. Cell Res. 312, 3443-3457 (2006).
113. Lebel, M., Lavoie, J., Gaudreault, I., Bronsard, M. & Drouin, R. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase 1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice. Am. J. Pathol. 162, 1559-1569 (2003).
114. Rossi, M. L., Ghosh, A. K. & Bohr, V. A. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair 9, 331-344 (2010).
115. Hewish, M., Lord, C. J., Martin, S. A., Cunningham, D. & Ashworth, A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nature Rev. Clin. Oncol. 7, 197-208 (2010).
116. Lahue, R. S., Au, K. G. & Modrich, P. DNA mismatch correction in a defined system. Science 245, 160-164 (1989).
117. Song, L., Yuan, F. & Zhang, Y. Does a helicase activity help mismatch repair in eukaryotes? IUBMB Life 62, 548-553 (2010).
118. Sharma, S. et al. The exonucleolytic and endonucleolytic cleavage activities of human exonuclease 1 are stimulated by an interaction with the carboxyl-terminal region of the Werner syndrome protein. J. Biol. Chem. 278, 23487-23496 (2003).
119. Doherty, K. M. et al. RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination. J. Biol. Chem. 280, 28085-28094 (2005).
120. Helleday, T. Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapy. Eur. J. Cancer 44, 921-927 (2008).
121. Hegnauer, A. M. et al. An. N terminal acidic region of Sgs1 interacts with Rpa70 and recruits Rad53 kinase to stalled forks. EMBO J. 31, 3768-3783 (2012).
122. Bjergbaek, L., Cobb, J. A., Tsai-Pflugfelder, M. & Gasser, S. M. Mechanistically distinct roles for Sgs1p in checkpoint activation and replication fork maintenance. EMBO J. 24, 405-417 (2005).
123. Frei, C. & Gasser, S. M. The yeast Sgs1p helicase acts upstream of Rad53p in the DNA replication checkpoint and colocalizes with Rad53p in S phase-specific foci. Genes Dev. 14, 81-96 (2000).
124. Doherty, K. M. et al. Physical and functional mapping of the RPA interaction domain of the Werner and Bloom syndrome helicases. J. Biol. Chem. 280, 29494-29505 (2005).
125. Sidorova, J. M., Li, N., Folch, A. & Monnat, R. J. Jr. The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest. Cell Cycle 7, 796-807 (2008).
126. Machwe, A., Xiao, L., Groden, J. & Orren, D. K. The Werner and Bloom syndrome proteins catalyze regression of a model replication fork. Biochemistry 45, 13939-13946 (2006).
127. Machwe, A., Karale, R., Xu, X., Liu, Y. & Orren, D. K. The Werner and Bloom syndrome proteins help resolve replication blockage by converting (regressed) Holliday junctions to functional replication forks. Biochemistry 50, 6774-6788 (2011).
128. Ralf, C., Hickson, I. D. & Wu, L. The Bloom's syndrome helicase can promote the regression of a model replication fork. J. Biol. Chem. 281, 22839-22846 (2006).
129. Berti, M. et al. Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition. Nature Struct. Mol. Biol. 20, 347-354 (2013).
130. Fugger, K. et al. FBH1 co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress. Nature Commun. 4, 1423 (2013).
131. Jeong, Y. T. et al. FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress. J. Cell Biol. 200, 141-149 (2013).
132. Kumaraswamy, E. & Shiekhattar, R. Activation of BRCA1/BRCA2- associated helicase BACH1 is required for timely progression through S phase. Mol. Cell. Biol. 27, 6733-6741 (2007).
133. Gong, Z., Kim, J. E., Leung, C. C., Glover, J. N. & Chen, J. BACH1/FANCJ acts with TopBP1 and participates early in DNA replication checkpoint control. Mol. Cell 37, 438-446 (2010).
134. Gari, K., Decaillet, C., Delannoy, M., Wu, L. & Constantinou, A. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl Acad. Sci. USA 105, 16107-16112 (2008).
135. Yan, Z. et al. A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol. Cell 37, 865-878 (2010).
136. Betous, R. et al. SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. Genes Dev. 26, 151-162 (2012).
137. Yusufzai, T. & Kadonaga, J. T. HARP is an ATP-driven annealing helicase. Science 322, 748-750 (2008).
138. Euskirchen, G., Auerbach, R. K. & Snyder, M. SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions. J. Biol. Chem. 287, 30897-30905 (2012).
139. Lai, A. Y. & Wade, P. A. Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nature Rev. Cancer 11, 588-596 (2011).
140. McGlynn, P., Savery, N. J. & Dillingham, M. S. The conflict between DNA replication and transcription. Mol. Microbiol. 85, 12-20 (2012).
141. de Septenville, A. L., Duigou, S., Boubakri, H. & Michel, B. Replication fork reversal after replication-transcription collision. PLoS Genet. 8, e1002622 (2012).
142. Lutzmann, M. et al. MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination. Mol. Cell 47, 523-534 (2012).
143. Nishimura, K. et al. Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks. Mol. Cell 47, 511-522 (2012).
144. Hartford, S. A. et al. Minichromosome maintenance helicase paralog MCM9 is dispensible for DNA replication but functions in germ-line stem cells and tumor suppression. Proc. Natl Acad. Sci. USA 108, 17702-17707 (2011).
145. Aguilera, A. & Garcia-Muse, T. R loops: from transcription byproducts to threats to genome stability. Mol. Cell 46, 115-124 (2012).
146. Sabouri, N., McDonald, K. R., Webb, C. J., Cristea, I. M. & Zakian, V. A. DNA replication through hard-to-replicate sites, including both highly transcribed RNA Pol II and Pol III genes, requires the S. pombe Pfh1 helicase. Genes Dev. 26, 581-593 (2012).
147. Steinacher, R., Osman, F., Dalgaard, J. Z., Lorenz, A. & Whitby, M. C. The DNA helicase Pfh1 promotes fork merging at replication termination sites to ensure genome stability. Genes Dev. 26, 594-602 (2012).
148. Bochman, M. L., Paeschke, K. & Zakian, V. A. DNA secondary structures: stability and function of G quadruplex structures. Nature Rev. Genet. 13, 770-780 (2012).
149. Wu, Y. & Brosh, R. M. Jr. G-quadruplex nucleic acids and human disease. FEBS J. 277, 3470-3488 (2010).
150. Paeschke, K., Capra, J. A. & Zakian, V. A. DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell 145, 678-691 (2011).
151. Ribeyre, C. et al. The yeast Pif1 helicase prevents genomic instability caused by G-quadruplex-forming CEB1 sequences in vivo. PLoS Genet. 5, e1000475 (2009).
152. Piazza, A. et al. Genetic instability triggered by G-quadruplex interacting Phen-DC compounds in Saccharomyces cerevisiae. Nucleic Acids Res. 38, 4337-4348 (2010).
153. Lopes, J. et al. G quadruplex-induced instability during leading-strand replication. EMBO J. 30, 4033-4046 (2011).
154. Cheung, I., Schertzer, M., Rose, A. & Lansdorp, P. M. Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA. Nature Genet. 31, 405-409 (2002).
155. Wu, Y., Shin-Ya, K. & Brosh, R. M. Jr. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol. Cell. Biol. 28, 4116-4128 (2008).
156. Shin Ya, K. et al. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc. 123, 1262-1263 (2001).
157. London, T. B. et al. FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts. J. Biol. Chem. 283, 36132-36139 (2008).
158. Balasubramanian, S., Hurley, L. H. & Neidle, S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nature Rev. Drug Discov. 10, 261-275 (2011).
159. Johnson, J. E., Cao, K., Ryvkin, P., Wang, L. S. & Johnson, F. B. Altered gene expression in the Werner and Bloom syndromes is associated with sequences having G-quadruplex forming potential. Nucleic Acids Res. 38, 1114-1122 (2010).
160. Corpet, A. & Almouzni, G. Making copies of chromatin: the challenge of nucleosomal organization and epigenetic information. Trends Cell Biol. 19, 29-41 (2009).
161. Sarkies, P., Reams, C., Simpson, L. J. & Sale, J. E. Epigenetic instability due to defective replication of structured DNA. Mol. Cell 40, 703-713 (2010).
162. Sarkies, P. et al. FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA. Nucleic Acids Res. 40, 1485-1498 (2012).
163. Schwab, R. A., Nieminuszczy, J., Shin-Ya, K. & Niedzwiedz, W. FANCJ couples replication past natural fork barriers with maintenance of chromatin structure. J. Cell Biol. 201, 33-48 (2013).
164. Kamath-Loeb, A. S., Lan, L., Nakajima, S., Yasui, A. & Loeb, L. A. Werner syndrome protein interacts functionally with translesion DNA polymerases. Proc. Natl Acad. Sci. USA 104, 10394-10399 (2007).
165. Kamath-Loeb, A. S., Shen, J. C., Schmitt, M. W. & Loeb, L. A. The Werner syndrome exonuclease facilitates DNA degradation and high fidelity DNA polymerization by human DNA polymerase σ. J. Biol. Chem. 287, 12480-12490 (2012).
166. Dejardin, J. & Kingston, R. E. Purification of proteins associated with specific genomic loci. Cell 136, 175-186 (2009).
167. Sfeir, A. et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90-103 (2009).
168. Opresko, P. L. et al. The Werner Syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell 14, 763-774 (2004).
169. Chang, S. et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nature Genet. 36, 877-882 (2004).
170. Du, X. et al. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol. Cell. Biol. 24, 8437-8446 (2004).
171. Laud, P. R. et al. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 19, 2560-2570 (2005).
172. Crabbe, L., Verdun, R. E., Haggblom, C. I. & Karlseder, J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306, 1951-1953 (2004).
173. Saharia, A. et al. Flap endonuclease 1 contributes to telomere stability. Curr. Biol. 18, 496-500 (2008).
174. Sharma, S. et al. WRN helicase and FEN-1 form a complex upon replication arrest and together process branch-migrating DNA structures associated with the replication fork. Mol. Biol. Cell 15, 734-750 (2004).
175. Fan, Q., Zhang, F., Barrett, B., Ren, K. & Andreassen, P. R. A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res. 37, 1740-1754 (2009).
176. Rhee, D. B. et al. FANCC suppresses short telomere-initiated telomere sister chromatid exchange. Hum. Mol. Genet. 19, 879-887 (2010).
177. Agrelo, R. et al. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc. Natl Acad. Sci. USA 103, 8822-8827 (2006).
178. Zoppoli, G. et al. Putative DNA/RNA helicase Schlafen 11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc. Natl Acad. Sci. USA 109, 15030-15035 (2012).
179. Curtin, N. J. DNA repair dysregulation from cancer driver to therapeutic target. Nature Rev. Cancer 12, 801-817 (2012).
180. Bouwman, P. & Jonkers, J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nature Rev. Cancer 12, 587-598 (2012).
181. Bryant, H. E. et al. Specific killing of BRCA2 deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913-917 (2005).
182. Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917-921 (2005).
183. Aggarwal, M. & Brosh, R. M. Jr. Hitting the bull's eye: novel directed cancer therapy through helicase-targeted synthetic lethality. J. Cell Biochem. 106, 758-763 (2009).
184. Moser, R. et al. MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency. Mol. Cancer Res. 10, 535-545 (2012).
185. Aggarwal, M., Sommers, J. A., Shoemaker, R. H. & Brosh, R. M. Jr. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress. Proc. Natl Acad. Sci. USA 108, 1525-1530 (2011).
186. Murai, J. et al. Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res. 72, 5588-5599 (2012).
187. Nguyen, G. H. et al. A small molecule Inhibitor of the BLM helicase modulates chromosome stability in human cells. Chem. Biol. 20, 55-62 (2013).
188. Shay, J. W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791 (1997).
189. Buseman, C. M., Wright, W. E. & Shay, J. W. Is telomerase a viable target in cancer? Mutat. Res. 730, 90-97 (2012).
190. Li, Q., Xiang, J. F., Zhang, H. & Tang, Y. L. Searching drug-like anti-cancer compound(s) based on G quadruplex ligands. Curr. Pharm. Des. 18, 1973-1983 (2012).
191. Gomez, D. et al. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J. Biol. Chem. 281, 38721-38729 (2006).
192. Rodriguez, R. et al. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J. Am. Chem. Soc. 130, 15758-15759 (2008).
193. Rodriguez, R. et al. Small-molecule-induced DNA damage identifies alternative DNA structures in human genes. Nature Chem. Biol. 8, 301-310 (2012).
194. Muller, S. et al. Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells. Org. Biomol. Chem. 10, 6537-6546 (2012).
195. Gocha, A. R., Harris, J. & Groden, J. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression. Mutat. Res. 743-744, 142-150 (2013).
196. Mackintosh, S. G. & Raney, K. D. DNA unwinding and protein displacement by superfamily 1 and superfamily 2 helicases. Nucleic Acids Res. 34, 4154-4159 (2006).
197. Rad, B. & Kowalczykowski, S. C. Efficient coupling of ATP hydrolysis to translocation by RecQ helicase. Proc. Natl Acad. Sci. USA 109, 1443-1448 (2012).
198. Sarlos, K., Gyimesi, M. & Kovacs, M. RecQ helicase translocates along single-stranded DNA with a moderate processivity and tight mechanochemical coupling. Proc. Natl Acad. Sci. USA 109, 9804-9809 (2012).
199. Patel, S. S. & Picha, K. M. Structure and function of hexameric helicases. Annu. Rev. Biochem. 69, 651-697 (2000).
200. Spies, M., Amitani, I., Baskin, R. J. & Kowalczykowski, S. C. RecBCD enzyme switches lead motor subunits in response to chi recognition. Cell 131, 694-705 (2007).
201. Wong, I. & Lohman, T. M. Allosteric effects of nucleotide cofactors on Escherichia coli Rep helicase-DNA binding. Science 256, 350-355 (1992).
202. Wu, Y. et al. Fanconi anemia Group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes. Blood 116, 3780-3791 (2010).
203. Zittel, M. C. & Keck, J. L. Coupling DNA-binding and ATP hydrolysis in Escherichia coli RecQ: role of a highly conserved aromatic-rich sequence. Nucleic Acids Res. 33, 6982-6991 (2005).
204. Wu, Y. et al. The Q Motif of FANCJ DNA helicase regulates its dimerization, DNA binding, and DNA repair function. J. Biol. Chem. 287, 21699-21716 (2012).
205. Heyer, W. D., Ehmsen, K. T. & Liu, J. Regulation of homologous recombination in eukaryotes. Annu. Rev. Genet. 44, 113-139 (2010).
206. Myong, S., Rasnik, I., Joo, C., Lohman, T. M. & Ha, T. Repetitive shuttling of a motor protein on DNA. Nature 437, 1321-1325 (2005).
207. Myong, S., Bruno, M. M., Pyle, A. M. & Ha, T. Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase. Science 317, 513-516 (2007).
208. Yodh, J. G., Stevens, B. C., Kanagaraj, R., Janscak, P. & Ha, T. BLM helicase measures DNA unwound before switching strands and hRPA promotes unwinding reinitiation. EMBO J. 28, 405-416 (2009).
209. Sun, B. et al. ATP-induced helicase slippage reveals highly coordinated subunits. Nature 478, 132-135 (2011).
210. Pike, A. C. et al. Structure of the human RECQ1 helicase reveals a putative strand-separation pin. Proc. Natl Acad. Sci. USA 106, 1039-1044 (2009).
211. Kuper, J., Wolski, S. C., Michels, G. & Kisker, C. Functional and structural studies of the nucleotide excision repair helicase XPD suggest a polarity for DNA translocation. EMBO J. 31, 494-502 (2011).
212. Brosh, R. M. Jr & Bohr, V. A. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res. 35, 7527-7544 (2007).
213. Sharma, S. et al. Biochemical analysis of the DNA unwinding and strand annealing activities catalyzed by human RECQ1. J. Biol. Chem. 280, 28072-28084 (2005).
214. Mazina, O. M., Rossi, M. J., Deakyne, J. S., Huang, F. & Mazin, A. V. Polarity and bypass of DNA heterology during branch migration of Holliday junctions by human RAD54, BLM, and RECQ1 proteins. J. Biol. Chem. 287, 11820-11832 (2012).
215. Wu, L. & Hickson, I. D. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426, 870-874 (2003).
216. Long, D. T., Raschle, M., Joukov, V. & Walter, J. C. Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science 333, 84-87 (2011).
217. Brosh, R. M. Jr et al. Werner syndrome protein interacts with human flap endonuclease 1 and stimulates its cleavage activity. EMBO J. 20, 5791-5801 (2001).
218. Sharma, S. et al. Stimulation of flap endonuclease-1 by the Bloom's syndrome protein. J. Biol. Chem. 279, 9847-9856 (2004).
219. Wang, W. & Bambara, R. A. Human Bloom protein stimulates flap endonuclease 1 activity by resolving DNA secondary structure. J. Biol. Chem. 280, 5391-5399 (2005).
220. Chan, N. L. et al. The Werner syndrome protein promotes CAG/CTG repeat stability by resolving large (CAG)(n)/(CTG)(n) hairpins. J. Biol. Chem. 287, 30151-30156 (2012).
221. Henry, R. A., Balakrishnan, L., Ying-Lin, S. T., Campbell, J. L. & Bambara, R. A. Components of the secondary pathway stimulate the primary pathway of eukaryotic Okazaki fragment processing. J. Biol. Chem. 285, 28496-28505 (2010).
222. McGlynn, P. Helicases that underpin replication of protein-bound DNA in Escherichia coli. Biochem. Soc. Trans. 39, 606-610 (2011).
223. Yin, J. et al. BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J. 24, 1465-1476 (2005).
224. Mao, F. J., Sidorova, J. M., Lauper, J. M., Emond, M. J. & Monnat, R. J. The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage. Cancer Res. 70, 6548-6555 (2010).
225. Popuri, V. et al. Recruitment and retention dynamics of RECQL5 at DNA double strand break sites. DNA Repair 11, 624-635 (2012).
226. Peng, M., Litman, R., Jin, Z., Fong, G. & Cantor, S. B. BACH1 is a DNA repair protein supporting BRCA1 damage response. Oncogene 25, 2245-2253 (2006).
227. Farina, A. et al. Studies with the human cohesin establishment factor, ChlR1. Association of ChlR1 with Ctf18 RFC and Fen1. J. Biol. Chem. 283, 20925-20936 (2008).
228. Parish, J. L. et al. The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells. J. Cell Sci. 119, 4857-4865 (2006).
229. Bhattacharya, C., Wang, X. & Becker, D. The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas. Mol. Cancer 11, 82 (2012).